Global CD31 Antibody Supply, Demand and Key Producers, 2023-2029
The global CD31 Antibody market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Growing patient base, launch of novel CD31 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD31 antibody market revenue.
CD31 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target CD31 in human, mouse, rat, rabbit and pig samples.
This report studies the global CD31 Antibody production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD31 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD31 Antibody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CD31 Antibody total production and demand, 2018-2029, (L)
Global CD31 Antibody total production value, 2018-2029, (USD Million)
Global CD31 Antibody production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (L)
Global CD31 Antibody consumption by region & country, CAGR, 2018-2029 & (L)
U.S. VS China: CD31 Antibody domestic production, consumption, key domestic manufacturers and share
Global CD31 Antibody production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (L)
Global CD31 Antibody production by Type, production, value, CAGR, 2018-2029, (USD Million) & (L)
Global CD31 Antibody production by Application production, value, CAGR, 2018-2029, (USD Million) & (L)
This reports profiles key players in the global CD31 Antibody market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BosterBio, Bio-Rad, Bioss, Thermo Fisher Scientific, NSJ Bioreagents, R and D Systems, Abcam, BioLegend and GeneTex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD31 Antibody market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (L) and average price (US$/L) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CD31 Antibody Market, By Region:
1. How big is the global CD31 Antibody market?
2. What is the demand of the global CD31 Antibody market?
3. What is the year over year growth of the global CD31 Antibody market?
4. What is the production and production value of the global CD31 Antibody market?
5. Who are the key producers in the global CD31 Antibody market?
6. What are the growth factors driving the market demand?
Growing patient base, launch of novel CD31 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD31 antibody market revenue.
CD31 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target CD31 in human, mouse, rat, rabbit and pig samples.
This report studies the global CD31 Antibody production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD31 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD31 Antibody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CD31 Antibody total production and demand, 2018-2029, (L)
Global CD31 Antibody total production value, 2018-2029, (USD Million)
Global CD31 Antibody production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (L)
Global CD31 Antibody consumption by region & country, CAGR, 2018-2029 & (L)
U.S. VS China: CD31 Antibody domestic production, consumption, key domestic manufacturers and share
Global CD31 Antibody production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (L)
Global CD31 Antibody production by Type, production, value, CAGR, 2018-2029, (USD Million) & (L)
Global CD31 Antibody production by Application production, value, CAGR, 2018-2029, (USD Million) & (L)
This reports profiles key players in the global CD31 Antibody market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BosterBio, Bio-Rad, Bioss, Thermo Fisher Scientific, NSJ Bioreagents, R and D Systems, Abcam, BioLegend and GeneTex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD31 Antibody market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (L) and average price (US$/L) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CD31 Antibody Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal
- Polyclonal
- Immunochemistry (IHC)
- Immunofluorescence (IF)
- Western Blot (WB)
- Immunocytochemistry (ICC)
- ELISA
- Others
- BosterBio
- Bio-Rad
- Bioss
- Thermo Fisher Scientific
- NSJ Bioreagents
- R and D Systems
- Abcam
- BioLegend
- GeneTex
- Novus Biologicals
- SouthernBiotech
- LifeSpan BioSciences
- Enzo Life Sciences
- Bethyl Laboratories
- Abbexa
- ProSci
- Proteintech
- Synaptic Systems
- BIOCARE MEDICAL
- CUSABIO Technology
- Absolute Antibody
- EpiGentek
- Biorbyt
- Wuhan Fine Biotech
- Sino Biological
1. How big is the global CD31 Antibody market?
2. What is the demand of the global CD31 Antibody market?
3. What is the year over year growth of the global CD31 Antibody market?
4. What is the production and production value of the global CD31 Antibody market?
5. Who are the key producers in the global CD31 Antibody market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CD31 Antibody Introduction
1.2 World CD31 Antibody Supply & Forecast
1.2.1 World CD31 Antibody Production Value (2018 & 2022 & 2029)
1.2.2 World CD31 Antibody Production (2018-2029)
1.2.3 World CD31 Antibody Pricing Trends (2018-2029)
1.3 World CD31 Antibody Production by Region (Based on Production Site)
1.3.1 World CD31 Antibody Production Value by Region (2018-2029)
1.3.2 World CD31 Antibody Production by Region (2018-2029)
1.3.3 World CD31 Antibody Average Price by Region (2018-2029)
1.3.4 North America CD31 Antibody Production (2018-2029)
1.3.5 Europe CD31 Antibody Production (2018-2029)
1.3.6 China CD31 Antibody Production (2018-2029)
1.3.7 Japan CD31 Antibody Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD31 Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD31 Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CD31 Antibody Demand (2018-2029)
2.2 World CD31 Antibody Consumption by Region
2.2.1 World CD31 Antibody Consumption by Region (2018-2023)
2.2.2 World CD31 Antibody Consumption Forecast by Region (2024-2029)
2.3 United States CD31 Antibody Consumption (2018-2029)
2.4 China CD31 Antibody Consumption (2018-2029)
2.5 Europe CD31 Antibody Consumption (2018-2029)
2.6 Japan CD31 Antibody Consumption (2018-2029)
2.7 South Korea CD31 Antibody Consumption (2018-2029)
2.8 ASEAN CD31 Antibody Consumption (2018-2029)
2.9 India CD31 Antibody Consumption (2018-2029)
3 WORLD CD31 ANTIBODY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CD31 Antibody Production Value by Manufacturer (2018-2023)
3.2 World CD31 Antibody Production by Manufacturer (2018-2023)
3.3 World CD31 Antibody Average Price by Manufacturer (2018-2023)
3.4 CD31 Antibody Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CD31 Antibody Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CD31 Antibody in 2022
3.5.3 Global Concentration Ratios (CR8) for CD31 Antibody in 2022
3.6 CD31 Antibody Market: Overall Company Footprint Analysis
3.6.1 CD31 Antibody Market: Region Footprint
3.6.2 CD31 Antibody Market: Company Product Type Footprint
3.6.3 CD31 Antibody Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CD31 Antibody Production Value Comparison
4.1.1 United States VS China: CD31 Antibody Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: CD31 Antibody Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: CD31 Antibody Production Comparison
4.2.1 United States VS China: CD31 Antibody Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CD31 Antibody Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: CD31 Antibody Consumption Comparison
4.3.1 United States VS China: CD31 Antibody Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: CD31 Antibody Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based CD31 Antibody Manufacturers and Market Share, 2018-2023
4.4.1 United States Based CD31 Antibody Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers CD31 Antibody Production Value (2018-2023)
4.4.3 United States Based Manufacturers CD31 Antibody Production (2018-2023)
4.5 China Based CD31 Antibody Manufacturers and Market Share
4.5.1 China Based CD31 Antibody Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers CD31 Antibody Production Value (2018-2023)
4.5.3 China Based Manufacturers CD31 Antibody Production (2018-2023)
4.6 Rest of World Based CD31 Antibody Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based CD31 Antibody Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers CD31 Antibody Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers CD31 Antibody Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CD31 Antibody Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal
5.2.2 Polyclonal
5.3 Market Segment by Type
5.3.1 World CD31 Antibody Production by Type (2018-2029)
5.3.2 World CD31 Antibody Production Value by Type (2018-2029)
5.3.3 World CD31 Antibody Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD31 Antibody Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Immunochemistry (IHC)
6.2.2 Immunofluorescence (IF)
6.2.3 Western Blot (WB)
6.2.4 Immunocytochemistry (ICC)
6.2.5 ELISA
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World CD31 Antibody Production by Application (2018-2029)
6.3.2 World CD31 Antibody Production Value by Application (2018-2029)
6.3.3 World CD31 Antibody Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 BosterBio
7.1.1 BosterBio Details
7.1.2 BosterBio Major Business
7.1.3 BosterBio CD31 Antibody Product and Services
7.1.4 BosterBio CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 BosterBio Recent Developments/Updates
7.1.6 BosterBio Competitive Strengths & Weaknesses
7.2 Bio-Rad
7.2.1 Bio-Rad Details
7.2.2 Bio-Rad Major Business
7.2.3 Bio-Rad CD31 Antibody Product and Services
7.2.4 Bio-Rad CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Rad Recent Developments/Updates
7.2.6 Bio-Rad Competitive Strengths & Weaknesses
7.3 Bioss
7.3.1 Bioss Details
7.3.2 Bioss Major Business
7.3.3 Bioss CD31 Antibody Product and Services
7.3.4 Bioss CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bioss Recent Developments/Updates
7.3.6 Bioss Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific CD31 Antibody Product and Services
7.4.4 Thermo Fisher Scientific CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 NSJ Bioreagents
7.5.1 NSJ Bioreagents Details
7.5.2 NSJ Bioreagents Major Business
7.5.3 NSJ Bioreagents CD31 Antibody Product and Services
7.5.4 NSJ Bioreagents CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 NSJ Bioreagents Recent Developments/Updates
7.5.6 NSJ Bioreagents Competitive Strengths & Weaknesses
7.6 R and D Systems
7.6.1 R and D Systems Details
7.6.2 R and D Systems Major Business
7.6.3 R and D Systems CD31 Antibody Product and Services
7.6.4 R and D Systems CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 R and D Systems Recent Developments/Updates
7.6.6 R and D Systems Competitive Strengths & Weaknesses
7.7 Abcam
7.7.1 Abcam Details
7.7.2 Abcam Major Business
7.7.3 Abcam CD31 Antibody Product and Services
7.7.4 Abcam CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Abcam Recent Developments/Updates
7.7.6 Abcam Competitive Strengths & Weaknesses
7.8 BioLegend
7.8.1 BioLegend Details
7.8.2 BioLegend Major Business
7.8.3 BioLegend CD31 Antibody Product and Services
7.8.4 BioLegend CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 BioLegend Recent Developments/Updates
7.8.6 BioLegend Competitive Strengths & Weaknesses
7.9 GeneTex
7.9.1 GeneTex Details
7.9.2 GeneTex Major Business
7.9.3 GeneTex CD31 Antibody Product and Services
7.9.4 GeneTex CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 GeneTex Recent Developments/Updates
7.9.6 GeneTex Competitive Strengths & Weaknesses
7.10 Novus Biologicals
7.10.1 Novus Biologicals Details
7.10.2 Novus Biologicals Major Business
7.10.3 Novus Biologicals CD31 Antibody Product and Services
7.10.4 Novus Biologicals CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Novus Biologicals Recent Developments/Updates
7.10.6 Novus Biologicals Competitive Strengths & Weaknesses
7.11 SouthernBiotech
7.11.1 SouthernBiotech Details
7.11.2 SouthernBiotech Major Business
7.11.3 SouthernBiotech CD31 Antibody Product and Services
7.11.4 SouthernBiotech CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 SouthernBiotech Recent Developments/Updates
7.11.6 SouthernBiotech Competitive Strengths & Weaknesses
7.12 LifeSpan BioSciences
7.12.1 LifeSpan BioSciences Details
7.12.2 LifeSpan BioSciences Major Business
7.12.3 LifeSpan BioSciences CD31 Antibody Product and Services
7.12.4 LifeSpan BioSciences CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 LifeSpan BioSciences Recent Developments/Updates
7.12.6 LifeSpan BioSciences Competitive Strengths & Weaknesses
7.13 Enzo Life Sciences
7.13.1 Enzo Life Sciences Details
7.13.2 Enzo Life Sciences Major Business
7.13.3 Enzo Life Sciences CD31 Antibody Product and Services
7.13.4 Enzo Life Sciences CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Enzo Life Sciences Recent Developments/Updates
7.13.6 Enzo Life Sciences Competitive Strengths & Weaknesses
7.14 Bethyl Laboratories
7.14.1 Bethyl Laboratories Details
7.14.2 Bethyl Laboratories Major Business
7.14.3 Bethyl Laboratories CD31 Antibody Product and Services
7.14.4 Bethyl Laboratories CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bethyl Laboratories Recent Developments/Updates
7.14.6 Bethyl Laboratories Competitive Strengths & Weaknesses
7.15 Abbexa
7.15.1 Abbexa Details
7.15.2 Abbexa Major Business
7.15.3 Abbexa CD31 Antibody Product and Services
7.15.4 Abbexa CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Abbexa Recent Developments/Updates
7.15.6 Abbexa Competitive Strengths & Weaknesses
7.16 ProSci
7.16.1 ProSci Details
7.16.2 ProSci Major Business
7.16.3 ProSci CD31 Antibody Product and Services
7.16.4 ProSci CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 ProSci Recent Developments/Updates
7.16.6 ProSci Competitive Strengths & Weaknesses
7.17 Proteintech
7.17.1 Proteintech Details
7.17.2 Proteintech Major Business
7.17.3 Proteintech CD31 Antibody Product and Services
7.17.4 Proteintech CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Proteintech Recent Developments/Updates
7.17.6 Proteintech Competitive Strengths & Weaknesses
7.18 Synaptic Systems
7.18.1 Synaptic Systems Details
7.18.2 Synaptic Systems Major Business
7.18.3 Synaptic Systems CD31 Antibody Product and Services
7.18.4 Synaptic Systems CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Synaptic Systems Recent Developments/Updates
7.18.6 Synaptic Systems Competitive Strengths & Weaknesses
7.19 BIOCARE MEDICAL
7.19.1 BIOCARE MEDICAL Details
7.19.2 BIOCARE MEDICAL Major Business
7.19.3 BIOCARE MEDICAL CD31 Antibody Product and Services
7.19.4 BIOCARE MEDICAL CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 BIOCARE MEDICAL Recent Developments/Updates
7.19.6 BIOCARE MEDICAL Competitive Strengths & Weaknesses
7.20 CUSABIO Technology
7.20.1 CUSABIO Technology Details
7.20.2 CUSABIO Technology Major Business
7.20.3 CUSABIO Technology CD31 Antibody Product and Services
7.20.4 CUSABIO Technology CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 CUSABIO Technology Recent Developments/Updates
7.20.6 CUSABIO Technology Competitive Strengths & Weaknesses
7.21 Absolute Antibody
7.21.1 Absolute Antibody Details
7.21.2 Absolute Antibody Major Business
7.21.3 Absolute Antibody CD31 Antibody Product and Services
7.21.4 Absolute Antibody CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Absolute Antibody Recent Developments/Updates
7.21.6 Absolute Antibody Competitive Strengths & Weaknesses
7.22 EpiGentek
7.22.1 EpiGentek Details
7.22.2 EpiGentek Major Business
7.22.3 EpiGentek CD31 Antibody Product and Services
7.22.4 EpiGentek CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 EpiGentek Recent Developments/Updates
7.22.6 EpiGentek Competitive Strengths & Weaknesses
7.23 Biorbyt
7.23.1 Biorbyt Details
7.23.2 Biorbyt Major Business
7.23.3 Biorbyt CD31 Antibody Product and Services
7.23.4 Biorbyt CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 Biorbyt Recent Developments/Updates
7.23.6 Biorbyt Competitive Strengths & Weaknesses
7.24 Wuhan Fine Biotech
7.24.1 Wuhan Fine Biotech Details
7.24.2 Wuhan Fine Biotech Major Business
7.24.3 Wuhan Fine Biotech CD31 Antibody Product and Services
7.24.4 Wuhan Fine Biotech CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 Wuhan Fine Biotech Recent Developments/Updates
7.24.6 Wuhan Fine Biotech Competitive Strengths & Weaknesses
7.25 Sino Biological
7.25.1 Sino Biological Details
7.25.2 Sino Biological Major Business
7.25.3 Sino Biological CD31 Antibody Product and Services
7.25.4 Sino Biological CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.25.5 Sino Biological Recent Developments/Updates
7.25.6 Sino Biological Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CD31 Antibody Industry Chain
8.2 CD31 Antibody Upstream Analysis
8.2.1 CD31 Antibody Core Raw Materials
8.2.2 Main Manufacturers of CD31 Antibody Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 CD31 Antibody Production Mode
8.6 CD31 Antibody Procurement Model
8.7 CD31 Antibody Industry Sales Model and Sales Channels
8.7.1 CD31 Antibody Sales Model
8.7.2 CD31 Antibody Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CD31 Antibody Introduction
1.2 World CD31 Antibody Supply & Forecast
1.2.1 World CD31 Antibody Production Value (2018 & 2022 & 2029)
1.2.2 World CD31 Antibody Production (2018-2029)
1.2.3 World CD31 Antibody Pricing Trends (2018-2029)
1.3 World CD31 Antibody Production by Region (Based on Production Site)
1.3.1 World CD31 Antibody Production Value by Region (2018-2029)
1.3.2 World CD31 Antibody Production by Region (2018-2029)
1.3.3 World CD31 Antibody Average Price by Region (2018-2029)
1.3.4 North America CD31 Antibody Production (2018-2029)
1.3.5 Europe CD31 Antibody Production (2018-2029)
1.3.6 China CD31 Antibody Production (2018-2029)
1.3.7 Japan CD31 Antibody Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD31 Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD31 Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CD31 Antibody Demand (2018-2029)
2.2 World CD31 Antibody Consumption by Region
2.2.1 World CD31 Antibody Consumption by Region (2018-2023)
2.2.2 World CD31 Antibody Consumption Forecast by Region (2024-2029)
2.3 United States CD31 Antibody Consumption (2018-2029)
2.4 China CD31 Antibody Consumption (2018-2029)
2.5 Europe CD31 Antibody Consumption (2018-2029)
2.6 Japan CD31 Antibody Consumption (2018-2029)
2.7 South Korea CD31 Antibody Consumption (2018-2029)
2.8 ASEAN CD31 Antibody Consumption (2018-2029)
2.9 India CD31 Antibody Consumption (2018-2029)
3 WORLD CD31 ANTIBODY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CD31 Antibody Production Value by Manufacturer (2018-2023)
3.2 World CD31 Antibody Production by Manufacturer (2018-2023)
3.3 World CD31 Antibody Average Price by Manufacturer (2018-2023)
3.4 CD31 Antibody Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CD31 Antibody Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CD31 Antibody in 2022
3.5.3 Global Concentration Ratios (CR8) for CD31 Antibody in 2022
3.6 CD31 Antibody Market: Overall Company Footprint Analysis
3.6.1 CD31 Antibody Market: Region Footprint
3.6.2 CD31 Antibody Market: Company Product Type Footprint
3.6.3 CD31 Antibody Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CD31 Antibody Production Value Comparison
4.1.1 United States VS China: CD31 Antibody Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: CD31 Antibody Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: CD31 Antibody Production Comparison
4.2.1 United States VS China: CD31 Antibody Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CD31 Antibody Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: CD31 Antibody Consumption Comparison
4.3.1 United States VS China: CD31 Antibody Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: CD31 Antibody Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based CD31 Antibody Manufacturers and Market Share, 2018-2023
4.4.1 United States Based CD31 Antibody Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers CD31 Antibody Production Value (2018-2023)
4.4.3 United States Based Manufacturers CD31 Antibody Production (2018-2023)
4.5 China Based CD31 Antibody Manufacturers and Market Share
4.5.1 China Based CD31 Antibody Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers CD31 Antibody Production Value (2018-2023)
4.5.3 China Based Manufacturers CD31 Antibody Production (2018-2023)
4.6 Rest of World Based CD31 Antibody Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based CD31 Antibody Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers CD31 Antibody Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers CD31 Antibody Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CD31 Antibody Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal
5.2.2 Polyclonal
5.3 Market Segment by Type
5.3.1 World CD31 Antibody Production by Type (2018-2029)
5.3.2 World CD31 Antibody Production Value by Type (2018-2029)
5.3.3 World CD31 Antibody Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD31 Antibody Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Immunochemistry (IHC)
6.2.2 Immunofluorescence (IF)
6.2.3 Western Blot (WB)
6.2.4 Immunocytochemistry (ICC)
6.2.5 ELISA
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World CD31 Antibody Production by Application (2018-2029)
6.3.2 World CD31 Antibody Production Value by Application (2018-2029)
6.3.3 World CD31 Antibody Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 BosterBio
7.1.1 BosterBio Details
7.1.2 BosterBio Major Business
7.1.3 BosterBio CD31 Antibody Product and Services
7.1.4 BosterBio CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 BosterBio Recent Developments/Updates
7.1.6 BosterBio Competitive Strengths & Weaknesses
7.2 Bio-Rad
7.2.1 Bio-Rad Details
7.2.2 Bio-Rad Major Business
7.2.3 Bio-Rad CD31 Antibody Product and Services
7.2.4 Bio-Rad CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Rad Recent Developments/Updates
7.2.6 Bio-Rad Competitive Strengths & Weaknesses
7.3 Bioss
7.3.1 Bioss Details
7.3.2 Bioss Major Business
7.3.3 Bioss CD31 Antibody Product and Services
7.3.4 Bioss CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bioss Recent Developments/Updates
7.3.6 Bioss Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific CD31 Antibody Product and Services
7.4.4 Thermo Fisher Scientific CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 NSJ Bioreagents
7.5.1 NSJ Bioreagents Details
7.5.2 NSJ Bioreagents Major Business
7.5.3 NSJ Bioreagents CD31 Antibody Product and Services
7.5.4 NSJ Bioreagents CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 NSJ Bioreagents Recent Developments/Updates
7.5.6 NSJ Bioreagents Competitive Strengths & Weaknesses
7.6 R and D Systems
7.6.1 R and D Systems Details
7.6.2 R and D Systems Major Business
7.6.3 R and D Systems CD31 Antibody Product and Services
7.6.4 R and D Systems CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 R and D Systems Recent Developments/Updates
7.6.6 R and D Systems Competitive Strengths & Weaknesses
7.7 Abcam
7.7.1 Abcam Details
7.7.2 Abcam Major Business
7.7.3 Abcam CD31 Antibody Product and Services
7.7.4 Abcam CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Abcam Recent Developments/Updates
7.7.6 Abcam Competitive Strengths & Weaknesses
7.8 BioLegend
7.8.1 BioLegend Details
7.8.2 BioLegend Major Business
7.8.3 BioLegend CD31 Antibody Product and Services
7.8.4 BioLegend CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 BioLegend Recent Developments/Updates
7.8.6 BioLegend Competitive Strengths & Weaknesses
7.9 GeneTex
7.9.1 GeneTex Details
7.9.2 GeneTex Major Business
7.9.3 GeneTex CD31 Antibody Product and Services
7.9.4 GeneTex CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 GeneTex Recent Developments/Updates
7.9.6 GeneTex Competitive Strengths & Weaknesses
7.10 Novus Biologicals
7.10.1 Novus Biologicals Details
7.10.2 Novus Biologicals Major Business
7.10.3 Novus Biologicals CD31 Antibody Product and Services
7.10.4 Novus Biologicals CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Novus Biologicals Recent Developments/Updates
7.10.6 Novus Biologicals Competitive Strengths & Weaknesses
7.11 SouthernBiotech
7.11.1 SouthernBiotech Details
7.11.2 SouthernBiotech Major Business
7.11.3 SouthernBiotech CD31 Antibody Product and Services
7.11.4 SouthernBiotech CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 SouthernBiotech Recent Developments/Updates
7.11.6 SouthernBiotech Competitive Strengths & Weaknesses
7.12 LifeSpan BioSciences
7.12.1 LifeSpan BioSciences Details
7.12.2 LifeSpan BioSciences Major Business
7.12.3 LifeSpan BioSciences CD31 Antibody Product and Services
7.12.4 LifeSpan BioSciences CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 LifeSpan BioSciences Recent Developments/Updates
7.12.6 LifeSpan BioSciences Competitive Strengths & Weaknesses
7.13 Enzo Life Sciences
7.13.1 Enzo Life Sciences Details
7.13.2 Enzo Life Sciences Major Business
7.13.3 Enzo Life Sciences CD31 Antibody Product and Services
7.13.4 Enzo Life Sciences CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Enzo Life Sciences Recent Developments/Updates
7.13.6 Enzo Life Sciences Competitive Strengths & Weaknesses
7.14 Bethyl Laboratories
7.14.1 Bethyl Laboratories Details
7.14.2 Bethyl Laboratories Major Business
7.14.3 Bethyl Laboratories CD31 Antibody Product and Services
7.14.4 Bethyl Laboratories CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bethyl Laboratories Recent Developments/Updates
7.14.6 Bethyl Laboratories Competitive Strengths & Weaknesses
7.15 Abbexa
7.15.1 Abbexa Details
7.15.2 Abbexa Major Business
7.15.3 Abbexa CD31 Antibody Product and Services
7.15.4 Abbexa CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Abbexa Recent Developments/Updates
7.15.6 Abbexa Competitive Strengths & Weaknesses
7.16 ProSci
7.16.1 ProSci Details
7.16.2 ProSci Major Business
7.16.3 ProSci CD31 Antibody Product and Services
7.16.4 ProSci CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 ProSci Recent Developments/Updates
7.16.6 ProSci Competitive Strengths & Weaknesses
7.17 Proteintech
7.17.1 Proteintech Details
7.17.2 Proteintech Major Business
7.17.3 Proteintech CD31 Antibody Product and Services
7.17.4 Proteintech CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Proteintech Recent Developments/Updates
7.17.6 Proteintech Competitive Strengths & Weaknesses
7.18 Synaptic Systems
7.18.1 Synaptic Systems Details
7.18.2 Synaptic Systems Major Business
7.18.3 Synaptic Systems CD31 Antibody Product and Services
7.18.4 Synaptic Systems CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Synaptic Systems Recent Developments/Updates
7.18.6 Synaptic Systems Competitive Strengths & Weaknesses
7.19 BIOCARE MEDICAL
7.19.1 BIOCARE MEDICAL Details
7.19.2 BIOCARE MEDICAL Major Business
7.19.3 BIOCARE MEDICAL CD31 Antibody Product and Services
7.19.4 BIOCARE MEDICAL CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 BIOCARE MEDICAL Recent Developments/Updates
7.19.6 BIOCARE MEDICAL Competitive Strengths & Weaknesses
7.20 CUSABIO Technology
7.20.1 CUSABIO Technology Details
7.20.2 CUSABIO Technology Major Business
7.20.3 CUSABIO Technology CD31 Antibody Product and Services
7.20.4 CUSABIO Technology CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 CUSABIO Technology Recent Developments/Updates
7.20.6 CUSABIO Technology Competitive Strengths & Weaknesses
7.21 Absolute Antibody
7.21.1 Absolute Antibody Details
7.21.2 Absolute Antibody Major Business
7.21.3 Absolute Antibody CD31 Antibody Product and Services
7.21.4 Absolute Antibody CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Absolute Antibody Recent Developments/Updates
7.21.6 Absolute Antibody Competitive Strengths & Weaknesses
7.22 EpiGentek
7.22.1 EpiGentek Details
7.22.2 EpiGentek Major Business
7.22.3 EpiGentek CD31 Antibody Product and Services
7.22.4 EpiGentek CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 EpiGentek Recent Developments/Updates
7.22.6 EpiGentek Competitive Strengths & Weaknesses
7.23 Biorbyt
7.23.1 Biorbyt Details
7.23.2 Biorbyt Major Business
7.23.3 Biorbyt CD31 Antibody Product and Services
7.23.4 Biorbyt CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 Biorbyt Recent Developments/Updates
7.23.6 Biorbyt Competitive Strengths & Weaknesses
7.24 Wuhan Fine Biotech
7.24.1 Wuhan Fine Biotech Details
7.24.2 Wuhan Fine Biotech Major Business
7.24.3 Wuhan Fine Biotech CD31 Antibody Product and Services
7.24.4 Wuhan Fine Biotech CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 Wuhan Fine Biotech Recent Developments/Updates
7.24.6 Wuhan Fine Biotech Competitive Strengths & Weaknesses
7.25 Sino Biological
7.25.1 Sino Biological Details
7.25.2 Sino Biological Major Business
7.25.3 Sino Biological CD31 Antibody Product and Services
7.25.4 Sino Biological CD31 Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.25.5 Sino Biological Recent Developments/Updates
7.25.6 Sino Biological Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CD31 Antibody Industry Chain
8.2 CD31 Antibody Upstream Analysis
8.2.1 CD31 Antibody Core Raw Materials
8.2.2 Main Manufacturers of CD31 Antibody Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 CD31 Antibody Production Mode
8.6 CD31 Antibody Procurement Model
8.7 CD31 Antibody Industry Sales Model and Sales Channels
8.7.1 CD31 Antibody Sales Model
8.7.2 CD31 Antibody Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CD31 Antibody Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World CD31 Antibody Production Value by Region (2018-2023) & (USD Million)
Table 3. World CD31 Antibody Production Value by Region (2024-2029) & (USD Million)
Table 4. World CD31 Antibody Production Value Market Share by Region (2018-2023)
Table 5. World CD31 Antibody Production Value Market Share by Region (2024-2029)
Table 6. World CD31 Antibody Production by Region (2018-2023) & (L)
Table 7. World CD31 Antibody Production by Region (2024-2029) & (L)
Table 8. World CD31 Antibody Production Market Share by Region (2018-2023)
Table 9. World CD31 Antibody Production Market Share by Region (2024-2029)
Table 10. World CD31 Antibody Average Price by Region (2018-2023) & (US$/L)
Table 11. World CD31 Antibody Average Price by Region (2024-2029) & (US$/L)
Table 12. CD31 Antibody Major Market Trends
Table 13. World CD31 Antibody Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (L)
Table 14. World CD31 Antibody Consumption by Region (2018-2023) & (L)
Table 15. World CD31 Antibody Consumption Forecast by Region (2024-2029) & (L)
Table 16. World CD31 Antibody Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key CD31 Antibody Producers in 2022
Table 18. World CD31 Antibody Production by Manufacturer (2018-2023) & (L)
Table 19. Production Market Share of Key CD31 Antibody Producers in 2022
Table 20. World CD31 Antibody Average Price by Manufacturer (2018-2023) & (US$/L)
Table 21. Global CD31 Antibody Company Evaluation Quadrant
Table 22. World CD31 Antibody Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and CD31 Antibody Production Site of Key Manufacturer
Table 24. CD31 Antibody Market: Company Product Type Footprint
Table 25. CD31 Antibody Market: Company Product Application Footprint
Table 26. CD31 Antibody Competitive Factors
Table 27. CD31 Antibody New Entrant and Capacity Expansion Plans
Table 28. CD31 Antibody Mergers & Acquisitions Activity
Table 29. United States VS China CD31 Antibody Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China CD31 Antibody Production Comparison, (2018 & 2022 & 2029) & (L)
Table 31. United States VS China CD31 Antibody Consumption Comparison, (2018 & 2022 & 2029) & (L)
Table 32. United States Based CD31 Antibody Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers CD31 Antibody Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers CD31 Antibody Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers CD31 Antibody Production (2018-2023) & (L)
Table 36. United States Based Manufacturers CD31 Antibody Production Market Share (2018-2023)
Table 37. China Based CD31 Antibody Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers CD31 Antibody Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers CD31 Antibody Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers CD31 Antibody Production (2018-2023) & (L)
Table 41. China Based Manufacturers CD31 Antibody Production Market Share (2018-2023)
Table 42. Rest of World Based CD31 Antibody Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers CD31 Antibody Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers CD31 Antibody Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers CD31 Antibody Production (2018-2023) & (L)
Table 46. Rest of World Based Manufacturers CD31 Antibody Production Market Share (2018-2023)
Table 47. World CD31 Antibody Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World CD31 Antibody Production by Type (2018-2023) & (L)
Table 49. World CD31 Antibody Production by Type (2024-2029) & (L)
Table 50. World CD31 Antibody Production Value by Type (2018-2023) & (USD Million)
Table 51. World CD31 Antibody Production Value by Type (2024-2029) & (USD Million)
Table 52. World CD31 Antibody Average Price by Type (2018-2023) & (US$/L)
Table 53. World CD31 Antibody Average Price by Type (2024-2029) & (US$/L)
Table 54. World CD31 Antibody Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World CD31 Antibody Production by Application (2018-2023) & (L)
Table 56. World CD31 Antibody Production by Application (2024-2029) & (L)
Table 57. World CD31 Antibody Production Value by Application (2018-2023) & (USD Million)
Table 58. World CD31 Antibody Production Value by Application (2024-2029) & (USD Million)
Table 59. World CD31 Antibody Average Price by Application (2018-2023) & (US$/L)
Table 60. World CD31 Antibody Average Price by Application (2024-2029) & (US$/L)
Table 61. BosterBio Basic Information, Manufacturing Base and Competitors
Table 62. BosterBio Major Business
Table 63. BosterBio CD31 Antibody Product and Services
Table 64. BosterBio CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. BosterBio Recent Developments/Updates
Table 66. BosterBio Competitive Strengths & Weaknesses
Table 67. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 68. Bio-Rad Major Business
Table 69. Bio-Rad CD31 Antibody Product and Services
Table 70. Bio-Rad CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bio-Rad Recent Developments/Updates
Table 72. Bio-Rad Competitive Strengths & Weaknesses
Table 73. Bioss Basic Information, Manufacturing Base and Competitors
Table 74. Bioss Major Business
Table 75. Bioss CD31 Antibody Product and Services
Table 76. Bioss CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bioss Recent Developments/Updates
Table 78. Bioss Competitive Strengths & Weaknesses
Table 79. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 80. Thermo Fisher Scientific Major Business
Table 81. Thermo Fisher Scientific CD31 Antibody Product and Services
Table 82. Thermo Fisher Scientific CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Thermo Fisher Scientific Recent Developments/Updates
Table 84. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 85. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 86. NSJ Bioreagents Major Business
Table 87. NSJ Bioreagents CD31 Antibody Product and Services
Table 88. NSJ Bioreagents CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. NSJ Bioreagents Recent Developments/Updates
Table 90. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 91. R and D Systems Basic Information, Manufacturing Base and Competitors
Table 92. R and D Systems Major Business
Table 93. R and D Systems CD31 Antibody Product and Services
Table 94. R and D Systems CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. R and D Systems Recent Developments/Updates
Table 96. R and D Systems Competitive Strengths & Weaknesses
Table 97. Abcam Basic Information, Manufacturing Base and Competitors
Table 98. Abcam Major Business
Table 99. Abcam CD31 Antibody Product and Services
Table 100. Abcam CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Abcam Recent Developments/Updates
Table 102. Abcam Competitive Strengths & Weaknesses
Table 103. BioLegend Basic Information, Manufacturing Base and Competitors
Table 104. BioLegend Major Business
Table 105. BioLegend CD31 Antibody Product and Services
Table 106. BioLegend CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. BioLegend Recent Developments/Updates
Table 108. BioLegend Competitive Strengths & Weaknesses
Table 109. GeneTex Basic Information, Manufacturing Base and Competitors
Table 110. GeneTex Major Business
Table 111. GeneTex CD31 Antibody Product and Services
Table 112. GeneTex CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. GeneTex Recent Developments/Updates
Table 114. GeneTex Competitive Strengths & Weaknesses
Table 115. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 116. Novus Biologicals Major Business
Table 117. Novus Biologicals CD31 Antibody Product and Services
Table 118. Novus Biologicals CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Novus Biologicals Recent Developments/Updates
Table 120. Novus Biologicals Competitive Strengths & Weaknesses
Table 121. SouthernBiotech Basic Information, Manufacturing Base and Competitors
Table 122. SouthernBiotech Major Business
Table 123. SouthernBiotech CD31 Antibody Product and Services
Table 124. SouthernBiotech CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. SouthernBiotech Recent Developments/Updates
Table 126. SouthernBiotech Competitive Strengths & Weaknesses
Table 127. LifeSpan BioSciences Basic Information, Manufacturing Base and Competitors
Table 128. LifeSpan BioSciences Major Business
Table 129. LifeSpan BioSciences CD31 Antibody Product and Services
Table 130. LifeSpan BioSciences CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. LifeSpan BioSciences Recent Developments/Updates
Table 132. LifeSpan BioSciences Competitive Strengths & Weaknesses
Table 133. Enzo Life Sciences Basic Information, Manufacturing Base and Competitors
Table 134. Enzo Life Sciences Major Business
Table 135. Enzo Life Sciences CD31 Antibody Product and Services
Table 136. Enzo Life Sciences CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Enzo Life Sciences Recent Developments/Updates
Table 138. Enzo Life Sciences Competitive Strengths & Weaknesses
Table 139. Bethyl Laboratories Basic Information, Manufacturing Base and Competitors
Table 140. Bethyl Laboratories Major Business
Table 141. Bethyl Laboratories CD31 Antibody Product and Services
Table 142. Bethyl Laboratories CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bethyl Laboratories Recent Developments/Updates
Table 144. Bethyl Laboratories Competitive Strengths & Weaknesses
Table 145. Abbexa Basic Information, Manufacturing Base and Competitors
Table 146. Abbexa Major Business
Table 147. Abbexa CD31 Antibody Product and Services
Table 148. Abbexa CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Abbexa Recent Developments/Updates
Table 150. Abbexa Competitive Strengths & Weaknesses
Table 151. ProSci Basic Information, Manufacturing Base and Competitors
Table 152. ProSci Major Business
Table 153. ProSci CD31 Antibody Product and Services
Table 154. ProSci CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. ProSci Recent Developments/Updates
Table 156. ProSci Competitive Strengths & Weaknesses
Table 157. Proteintech Basic Information, Manufacturing Base and Competitors
Table 158. Proteintech Major Business
Table 159. Proteintech CD31 Antibody Product and Services
Table 160. Proteintech CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Proteintech Recent Developments/Updates
Table 162. Proteintech Competitive Strengths & Weaknesses
Table 163. Synaptic Systems Basic Information, Manufacturing Base and Competitors
Table 164. Synaptic Systems Major Business
Table 165. Synaptic Systems CD31 Antibody Product and Services
Table 166. Synaptic Systems CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Synaptic Systems Recent Developments/Updates
Table 168. Synaptic Systems Competitive Strengths & Weaknesses
Table 169. BIOCARE MEDICAL Basic Information, Manufacturing Base and Competitors
Table 170. BIOCARE MEDICAL Major Business
Table 171. BIOCARE MEDICAL CD31 Antibody Product and Services
Table 172. BIOCARE MEDICAL CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. BIOCARE MEDICAL Recent Developments/Updates
Table 174. BIOCARE MEDICAL Competitive Strengths & Weaknesses
Table 175. CUSABIO Technology Basic Information, Manufacturing Base and Competitors
Table 176. CUSABIO Technology Major Business
Table 177. CUSABIO Technology CD31 Antibody Product and Services
Table 178. CUSABIO Technology CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. CUSABIO Technology Recent Developments/Updates
Table 180. CUSABIO Technology Competitive Strengths & Weaknesses
Table 181. Absolute Antibody Basic Information, Manufacturing Base and Competitors
Table 182. Absolute Antibody Major Business
Table 183. Absolute Antibody CD31 Antibody Product and Services
Table 184. Absolute Antibody CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. Absolute Antibody Recent Developments/Updates
Table 186. Absolute Antibody Competitive Strengths & Weaknesses
Table 187. EpiGentek Basic Information, Manufacturing Base and Competitors
Table 188. EpiGentek Major Business
Table 189. EpiGentek CD31 Antibody Product and Services
Table 190. EpiGentek CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. EpiGentek Recent Developments/Updates
Table 192. EpiGentek Competitive Strengths & Weaknesses
Table 193. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 194. Biorbyt Major Business
Table 195. Biorbyt CD31 Antibody Product and Services
Table 196. Biorbyt CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. Biorbyt Recent Developments/Updates
Table 198. Biorbyt Competitive Strengths & Weaknesses
Table 199. Wuhan Fine Biotech Basic Information, Manufacturing Base and Competitors
Table 200. Wuhan Fine Biotech Major Business
Table 201. Wuhan Fine Biotech CD31 Antibody Product and Services
Table 202. Wuhan Fine Biotech CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 203. Wuhan Fine Biotech Recent Developments/Updates
Table 204. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 205. Sino Biological Major Business
Table 206. Sino Biological CD31 Antibody Product and Services
Table 207. Sino Biological CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 208. Global Key Players of CD31 Antibody Upstream (Raw Materials)
Table 209. CD31 Antibody Typical Customers
Table 210. CD31 Antibody Typical Distributors
Table 1. World CD31 Antibody Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World CD31 Antibody Production Value by Region (2018-2023) & (USD Million)
Table 3. World CD31 Antibody Production Value by Region (2024-2029) & (USD Million)
Table 4. World CD31 Antibody Production Value Market Share by Region (2018-2023)
Table 5. World CD31 Antibody Production Value Market Share by Region (2024-2029)
Table 6. World CD31 Antibody Production by Region (2018-2023) & (L)
Table 7. World CD31 Antibody Production by Region (2024-2029) & (L)
Table 8. World CD31 Antibody Production Market Share by Region (2018-2023)
Table 9. World CD31 Antibody Production Market Share by Region (2024-2029)
Table 10. World CD31 Antibody Average Price by Region (2018-2023) & (US$/L)
Table 11. World CD31 Antibody Average Price by Region (2024-2029) & (US$/L)
Table 12. CD31 Antibody Major Market Trends
Table 13. World CD31 Antibody Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (L)
Table 14. World CD31 Antibody Consumption by Region (2018-2023) & (L)
Table 15. World CD31 Antibody Consumption Forecast by Region (2024-2029) & (L)
Table 16. World CD31 Antibody Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key CD31 Antibody Producers in 2022
Table 18. World CD31 Antibody Production by Manufacturer (2018-2023) & (L)
Table 19. Production Market Share of Key CD31 Antibody Producers in 2022
Table 20. World CD31 Antibody Average Price by Manufacturer (2018-2023) & (US$/L)
Table 21. Global CD31 Antibody Company Evaluation Quadrant
Table 22. World CD31 Antibody Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and CD31 Antibody Production Site of Key Manufacturer
Table 24. CD31 Antibody Market: Company Product Type Footprint
Table 25. CD31 Antibody Market: Company Product Application Footprint
Table 26. CD31 Antibody Competitive Factors
Table 27. CD31 Antibody New Entrant and Capacity Expansion Plans
Table 28. CD31 Antibody Mergers & Acquisitions Activity
Table 29. United States VS China CD31 Antibody Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China CD31 Antibody Production Comparison, (2018 & 2022 & 2029) & (L)
Table 31. United States VS China CD31 Antibody Consumption Comparison, (2018 & 2022 & 2029) & (L)
Table 32. United States Based CD31 Antibody Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers CD31 Antibody Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers CD31 Antibody Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers CD31 Antibody Production (2018-2023) & (L)
Table 36. United States Based Manufacturers CD31 Antibody Production Market Share (2018-2023)
Table 37. China Based CD31 Antibody Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers CD31 Antibody Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers CD31 Antibody Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers CD31 Antibody Production (2018-2023) & (L)
Table 41. China Based Manufacturers CD31 Antibody Production Market Share (2018-2023)
Table 42. Rest of World Based CD31 Antibody Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers CD31 Antibody Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers CD31 Antibody Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers CD31 Antibody Production (2018-2023) & (L)
Table 46. Rest of World Based Manufacturers CD31 Antibody Production Market Share (2018-2023)
Table 47. World CD31 Antibody Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World CD31 Antibody Production by Type (2018-2023) & (L)
Table 49. World CD31 Antibody Production by Type (2024-2029) & (L)
Table 50. World CD31 Antibody Production Value by Type (2018-2023) & (USD Million)
Table 51. World CD31 Antibody Production Value by Type (2024-2029) & (USD Million)
Table 52. World CD31 Antibody Average Price by Type (2018-2023) & (US$/L)
Table 53. World CD31 Antibody Average Price by Type (2024-2029) & (US$/L)
Table 54. World CD31 Antibody Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World CD31 Antibody Production by Application (2018-2023) & (L)
Table 56. World CD31 Antibody Production by Application (2024-2029) & (L)
Table 57. World CD31 Antibody Production Value by Application (2018-2023) & (USD Million)
Table 58. World CD31 Antibody Production Value by Application (2024-2029) & (USD Million)
Table 59. World CD31 Antibody Average Price by Application (2018-2023) & (US$/L)
Table 60. World CD31 Antibody Average Price by Application (2024-2029) & (US$/L)
Table 61. BosterBio Basic Information, Manufacturing Base and Competitors
Table 62. BosterBio Major Business
Table 63. BosterBio CD31 Antibody Product and Services
Table 64. BosterBio CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. BosterBio Recent Developments/Updates
Table 66. BosterBio Competitive Strengths & Weaknesses
Table 67. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 68. Bio-Rad Major Business
Table 69. Bio-Rad CD31 Antibody Product and Services
Table 70. Bio-Rad CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bio-Rad Recent Developments/Updates
Table 72. Bio-Rad Competitive Strengths & Weaknesses
Table 73. Bioss Basic Information, Manufacturing Base and Competitors
Table 74. Bioss Major Business
Table 75. Bioss CD31 Antibody Product and Services
Table 76. Bioss CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bioss Recent Developments/Updates
Table 78. Bioss Competitive Strengths & Weaknesses
Table 79. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 80. Thermo Fisher Scientific Major Business
Table 81. Thermo Fisher Scientific CD31 Antibody Product and Services
Table 82. Thermo Fisher Scientific CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Thermo Fisher Scientific Recent Developments/Updates
Table 84. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 85. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 86. NSJ Bioreagents Major Business
Table 87. NSJ Bioreagents CD31 Antibody Product and Services
Table 88. NSJ Bioreagents CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. NSJ Bioreagents Recent Developments/Updates
Table 90. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 91. R and D Systems Basic Information, Manufacturing Base and Competitors
Table 92. R and D Systems Major Business
Table 93. R and D Systems CD31 Antibody Product and Services
Table 94. R and D Systems CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. R and D Systems Recent Developments/Updates
Table 96. R and D Systems Competitive Strengths & Weaknesses
Table 97. Abcam Basic Information, Manufacturing Base and Competitors
Table 98. Abcam Major Business
Table 99. Abcam CD31 Antibody Product and Services
Table 100. Abcam CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Abcam Recent Developments/Updates
Table 102. Abcam Competitive Strengths & Weaknesses
Table 103. BioLegend Basic Information, Manufacturing Base and Competitors
Table 104. BioLegend Major Business
Table 105. BioLegend CD31 Antibody Product and Services
Table 106. BioLegend CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. BioLegend Recent Developments/Updates
Table 108. BioLegend Competitive Strengths & Weaknesses
Table 109. GeneTex Basic Information, Manufacturing Base and Competitors
Table 110. GeneTex Major Business
Table 111. GeneTex CD31 Antibody Product and Services
Table 112. GeneTex CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. GeneTex Recent Developments/Updates
Table 114. GeneTex Competitive Strengths & Weaknesses
Table 115. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 116. Novus Biologicals Major Business
Table 117. Novus Biologicals CD31 Antibody Product and Services
Table 118. Novus Biologicals CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Novus Biologicals Recent Developments/Updates
Table 120. Novus Biologicals Competitive Strengths & Weaknesses
Table 121. SouthernBiotech Basic Information, Manufacturing Base and Competitors
Table 122. SouthernBiotech Major Business
Table 123. SouthernBiotech CD31 Antibody Product and Services
Table 124. SouthernBiotech CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. SouthernBiotech Recent Developments/Updates
Table 126. SouthernBiotech Competitive Strengths & Weaknesses
Table 127. LifeSpan BioSciences Basic Information, Manufacturing Base and Competitors
Table 128. LifeSpan BioSciences Major Business
Table 129. LifeSpan BioSciences CD31 Antibody Product and Services
Table 130. LifeSpan BioSciences CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. LifeSpan BioSciences Recent Developments/Updates
Table 132. LifeSpan BioSciences Competitive Strengths & Weaknesses
Table 133. Enzo Life Sciences Basic Information, Manufacturing Base and Competitors
Table 134. Enzo Life Sciences Major Business
Table 135. Enzo Life Sciences CD31 Antibody Product and Services
Table 136. Enzo Life Sciences CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Enzo Life Sciences Recent Developments/Updates
Table 138. Enzo Life Sciences Competitive Strengths & Weaknesses
Table 139. Bethyl Laboratories Basic Information, Manufacturing Base and Competitors
Table 140. Bethyl Laboratories Major Business
Table 141. Bethyl Laboratories CD31 Antibody Product and Services
Table 142. Bethyl Laboratories CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bethyl Laboratories Recent Developments/Updates
Table 144. Bethyl Laboratories Competitive Strengths & Weaknesses
Table 145. Abbexa Basic Information, Manufacturing Base and Competitors
Table 146. Abbexa Major Business
Table 147. Abbexa CD31 Antibody Product and Services
Table 148. Abbexa CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Abbexa Recent Developments/Updates
Table 150. Abbexa Competitive Strengths & Weaknesses
Table 151. ProSci Basic Information, Manufacturing Base and Competitors
Table 152. ProSci Major Business
Table 153. ProSci CD31 Antibody Product and Services
Table 154. ProSci CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. ProSci Recent Developments/Updates
Table 156. ProSci Competitive Strengths & Weaknesses
Table 157. Proteintech Basic Information, Manufacturing Base and Competitors
Table 158. Proteintech Major Business
Table 159. Proteintech CD31 Antibody Product and Services
Table 160. Proteintech CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Proteintech Recent Developments/Updates
Table 162. Proteintech Competitive Strengths & Weaknesses
Table 163. Synaptic Systems Basic Information, Manufacturing Base and Competitors
Table 164. Synaptic Systems Major Business
Table 165. Synaptic Systems CD31 Antibody Product and Services
Table 166. Synaptic Systems CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Synaptic Systems Recent Developments/Updates
Table 168. Synaptic Systems Competitive Strengths & Weaknesses
Table 169. BIOCARE MEDICAL Basic Information, Manufacturing Base and Competitors
Table 170. BIOCARE MEDICAL Major Business
Table 171. BIOCARE MEDICAL CD31 Antibody Product and Services
Table 172. BIOCARE MEDICAL CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. BIOCARE MEDICAL Recent Developments/Updates
Table 174. BIOCARE MEDICAL Competitive Strengths & Weaknesses
Table 175. CUSABIO Technology Basic Information, Manufacturing Base and Competitors
Table 176. CUSABIO Technology Major Business
Table 177. CUSABIO Technology CD31 Antibody Product and Services
Table 178. CUSABIO Technology CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. CUSABIO Technology Recent Developments/Updates
Table 180. CUSABIO Technology Competitive Strengths & Weaknesses
Table 181. Absolute Antibody Basic Information, Manufacturing Base and Competitors
Table 182. Absolute Antibody Major Business
Table 183. Absolute Antibody CD31 Antibody Product and Services
Table 184. Absolute Antibody CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. Absolute Antibody Recent Developments/Updates
Table 186. Absolute Antibody Competitive Strengths & Weaknesses
Table 187. EpiGentek Basic Information, Manufacturing Base and Competitors
Table 188. EpiGentek Major Business
Table 189. EpiGentek CD31 Antibody Product and Services
Table 190. EpiGentek CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. EpiGentek Recent Developments/Updates
Table 192. EpiGentek Competitive Strengths & Weaknesses
Table 193. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 194. Biorbyt Major Business
Table 195. Biorbyt CD31 Antibody Product and Services
Table 196. Biorbyt CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. Biorbyt Recent Developments/Updates
Table 198. Biorbyt Competitive Strengths & Weaknesses
Table 199. Wuhan Fine Biotech Basic Information, Manufacturing Base and Competitors
Table 200. Wuhan Fine Biotech Major Business
Table 201. Wuhan Fine Biotech CD31 Antibody Product and Services
Table 202. Wuhan Fine Biotech CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 203. Wuhan Fine Biotech Recent Developments/Updates
Table 204. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 205. Sino Biological Major Business
Table 206. Sino Biological CD31 Antibody Product and Services
Table 207. Sino Biological CD31 Antibody Production (L), Price (US$/L), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 208. Global Key Players of CD31 Antibody Upstream (Raw Materials)
Table 209. CD31 Antibody Typical Customers
Table 210. CD31 Antibody Typical Distributors
LIST OF FIGURES
Figure 1. CD31 Antibody Picture
Figure 2. World CD31 Antibody Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CD31 Antibody Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World CD31 Antibody Production (2018-2029) & (L)
Figure 5. World CD31 Antibody Average Price (2018-2029) & (US$/L)
Figure 6. World CD31 Antibody Production Value Market Share by Region (2018-2029)
Figure 7. World CD31 Antibody Production Market Share by Region (2018-2029)
Figure 8. North America CD31 Antibody Production (2018-2029) & (L)
Figure 9. Europe CD31 Antibody Production (2018-2029) & (L)
Figure 10. China CD31 Antibody Production (2018-2029) & (L)
Figure 11. Japan CD31 Antibody Production (2018-2029) & (L)
Figure 12. CD31 Antibody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CD31 Antibody Consumption (2018-2029) & (L)
Figure 15. World CD31 Antibody Consumption Market Share by Region (2018-2029)
Figure 16. United States CD31 Antibody Consumption (2018-2029) & (L)
Figure 17. China CD31 Antibody Consumption (2018-2029) & (L)
Figure 18. Europe CD31 Antibody Consumption (2018-2029) & (L)
Figure 19. Japan CD31 Antibody Consumption (2018-2029) & (L)
Figure 20. South Korea CD31 Antibody Consumption (2018-2029) & (L)
Figure 21. ASEAN CD31 Antibody Consumption (2018-2029) & (L)
Figure 22. India CD31 Antibody Consumption (2018-2029) & (L)
Figure 23. Producer Shipments of CD31 Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for CD31 Antibody Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for CD31 Antibody Markets in 2022
Figure 26. United States VS China: CD31 Antibody Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: CD31 Antibody Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CD31 Antibody Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers CD31 Antibody Production Market Share 2022
Figure 30. China Based Manufacturers CD31 Antibody Production Market Share 2022
Figure 31. Rest of World Based Manufacturers CD31 Antibody Production Market Share 2022
Figure 32. World CD31 Antibody Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World CD31 Antibody Production Value Market Share by Type in 2022
Figure 34. Monoclonal
Figure 35. Polyclonal
Figure 36. World CD31 Antibody Production Market Share by Type (2018-2029)
Figure 37. World CD31 Antibody Production Value Market Share by Type (2018-2029)
Figure 38. World CD31 Antibody Average Price by Type (2018-2029) & (US$/L)
Figure 39. World CD31 Antibody Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World CD31 Antibody Production Value Market Share by Application in 2022
Figure 41. Immunochemistry (IHC)
Figure 42. Immunofluorescence (IF)
Figure 43. Western Blot (WB)
Figure 44. Immunocytochemistry (ICC)
Figure 45. ELISA
Figure 46. Others
Figure 47. World CD31 Antibody Production Market Share by Application (2018-2029)
Figure 48. World CD31 Antibody Production Value Market Share by Application (2018-2029)
Figure 49. World CD31 Antibody Average Price by Application (2018-2029) & (US$/L)
Figure 50. CD31 Antibody Industry Chain
Figure 51. CD31 Antibody Procurement Model
Figure 52. CD31 Antibody Sales Model
Figure 53. CD31 Antibody Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. CD31 Antibody Picture
Figure 2. World CD31 Antibody Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CD31 Antibody Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World CD31 Antibody Production (2018-2029) & (L)
Figure 5. World CD31 Antibody Average Price (2018-2029) & (US$/L)
Figure 6. World CD31 Antibody Production Value Market Share by Region (2018-2029)
Figure 7. World CD31 Antibody Production Market Share by Region (2018-2029)
Figure 8. North America CD31 Antibody Production (2018-2029) & (L)
Figure 9. Europe CD31 Antibody Production (2018-2029) & (L)
Figure 10. China CD31 Antibody Production (2018-2029) & (L)
Figure 11. Japan CD31 Antibody Production (2018-2029) & (L)
Figure 12. CD31 Antibody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CD31 Antibody Consumption (2018-2029) & (L)
Figure 15. World CD31 Antibody Consumption Market Share by Region (2018-2029)
Figure 16. United States CD31 Antibody Consumption (2018-2029) & (L)
Figure 17. China CD31 Antibody Consumption (2018-2029) & (L)
Figure 18. Europe CD31 Antibody Consumption (2018-2029) & (L)
Figure 19. Japan CD31 Antibody Consumption (2018-2029) & (L)
Figure 20. South Korea CD31 Antibody Consumption (2018-2029) & (L)
Figure 21. ASEAN CD31 Antibody Consumption (2018-2029) & (L)
Figure 22. India CD31 Antibody Consumption (2018-2029) & (L)
Figure 23. Producer Shipments of CD31 Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for CD31 Antibody Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for CD31 Antibody Markets in 2022
Figure 26. United States VS China: CD31 Antibody Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: CD31 Antibody Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CD31 Antibody Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers CD31 Antibody Production Market Share 2022
Figure 30. China Based Manufacturers CD31 Antibody Production Market Share 2022
Figure 31. Rest of World Based Manufacturers CD31 Antibody Production Market Share 2022
Figure 32. World CD31 Antibody Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World CD31 Antibody Production Value Market Share by Type in 2022
Figure 34. Monoclonal
Figure 35. Polyclonal
Figure 36. World CD31 Antibody Production Market Share by Type (2018-2029)
Figure 37. World CD31 Antibody Production Value Market Share by Type (2018-2029)
Figure 38. World CD31 Antibody Average Price by Type (2018-2029) & (US$/L)
Figure 39. World CD31 Antibody Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World CD31 Antibody Production Value Market Share by Application in 2022
Figure 41. Immunochemistry (IHC)
Figure 42. Immunofluorescence (IF)
Figure 43. Western Blot (WB)
Figure 44. Immunocytochemistry (ICC)
Figure 45. ELISA
Figure 46. Others
Figure 47. World CD31 Antibody Production Market Share by Application (2018-2029)
Figure 48. World CD31 Antibody Production Value Market Share by Application (2018-2029)
Figure 49. World CD31 Antibody Average Price by Application (2018-2029) & (US$/L)
Figure 50. CD31 Antibody Industry Chain
Figure 51. CD31 Antibody Procurement Model
Figure 52. CD31 Antibody Sales Model
Figure 53. CD31 Antibody Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
